Rights and permissions
About this article
Cite this article
Once-daily ceftriaxone + amikacin cost saving in febrile neutropenia. Pharmacoecon. Outcomes News 167, 6 (1998). https://doi.org/10.1007/BF03295978
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03295978